NervGen Pharma Corp. (NGEN)

1.73 -0.02 (-1.14%) USD  |  NASDAQ  |  Oct 09, 16:00
1.73 0.00 (0.00%) After-Hours: 20:00
More

NervGen Pharma Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for NGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
October 08, 2026 --
September 30, 2026 --
August 26, 2026 --
August 13, 2026 --
July 14, 2026 --
July 13, 2026 --
June 11, 2026 --
May 22, 2026 --
May 19, 2026 --
May 18, 2026 --
April 28, 2026 --
April 27, 2026 --
April 16, 2026 --
April 15, 2026 --
April 08, 2026 --
Date Value
March 31, 2026 --
January 08, 2026 --
January 02, 2026 --
December 11, 2025 --
November 24, 2025 --
October 06, 2025 --
August 26, 2025 --
July 17, 2025 --
June 17, 2025 --
June 02, 2025 --
May 15, 2025 --
April 17, 2025 --
April 30, 2024 --
September 08, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) --

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade